• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
Propranolol (MOA & PK)
MOA - Nonspecific beta receptor blocker, slow heart rate and reduce contractile force, inhibit rennin release from kidney, reduce aqueous humor secretion, bronchoconstriction, inhibit hepatic glycogenolysis, anesthetic properties
PK PO; extensive first pass metabolism; variable bioavailability; half life 3-6 hours
Propranolol (CU & T)
CU - Hypertension; glaucoma; ischemic heart disease; post-MI prophylaxis; stage fright, tremor; migraines; portal hypertension
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence
Penbutolol (MOA & PK)
MOA - Partial agonist, similar effects to propranolol, except incomplete blockade of lungs and heart function and no anesthetic action
PK - PO; high lipid solubility (CNS effects); good bioavailability; half-life 5 hours
Penbutolol (CU & T)
CU - Used for hypertension and angina when less bradycardia or bronchodilation is important
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence; less bradycardia and bronchodilation and perhaps more CNS effects than propranolol
Pindolol (MOA & PK)
MOA - Partial agonist, similar effects to propranolol, except incomplete blockade of lungs and heart function
PK - PO; moderate lipid solubility; good bioavailability; half-life 5 hours
Pindolol (CU & T)
CU - Used for hypertension and angina when less bradycardia or bronchodilation is important
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence; less bradycardia and bronchodilation and perhaps more CNS effects than propranolol
Carteolol (MOA & PK)
MOA - Partial agonist, similar effects to propranolol, except incomplete blockade of lungs and heart function and no anesthetic action
PK - PO/ophthalmic; low lipid solubility; good bioavailability; half-life 5 hours
Carteolol (CU & T)
CU - Glaucoma
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence; less CNS effects than penbutolol
Nadolol (MOA & PK)
MOA - Nonspecific beta receptor blocker, slow heart rate and reduce contractile force, inhibit rennin release from kidney, reduce aqueous humor secretion, bronchoconstriction, inhibit hepatic glycogenolysis
PK - PO; low lipid solubility; good bioavailability; long duration; half-life 14-24 hours
Nadolol (CU & T)
CU - Portal hypertension
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence; less CNS effects than penbutolol
Sotalol (MOA & PK)
MOA - Nonspecific beta receptor blocker, slow heart rate and reduce contractile force, inhibit rennin release from kidney, reduce aqueous humor secretion, bronchoconstriction, inhibit hepatic glycogenolysis
PK - PO; low lipid solubility; good bioavailability; long duration; half-life 12 hours
Sotalol (CU & T)
CU - Supraventricular arrhythmias
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence
Timolol (MOA & PK)
MOA - Nonspecific beta receptor blocker, slow heart rate and reduce contractile force, inhibit rennin release from kidney, reduce aqueous humor secretion, bronchoconstriction, inhibit hepatic glycogenolysis
PK - PO/ophthalmic; moderate lipid solubility; good bioavailability; half-life 5 hours
Timolol (CU & T)
CU -Topical glaucoma treatment
T - Bronchoconstriction, bradycardia, negative inotropy, hypotension, arrhythmias, sedation, depression, reduce recovery from hypoglycemia, withdrawal may occur, impotence